Antimycobacterial Agents Against Mycobacterium avium subsp. paratuberculosis
Author Information
Author(s): Zanetti Stefania, Molicotti Paola, Cannas Sara, Ortu Silvia, Ahmed Niyaz, Sechi Leonardo A
Primary Institution: Dipartimento di Scienze Biomediche, Università degli studi di Sassari
Hypothesis
The study investigates the in vitro activities of various antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's Disease.
Conclusion
The study found that certain antimycobacterial agents showed promising in vitro activity against Mycobacterium avium subsp. paratuberculosis.
Supporting Evidence
- Streptomycin, rifabutin, and rifampin showed low MIC values against the tested strains.
- Ciprofloxacin also demonstrated a low MIC range.
- Dapsone had a very high MIC value, indicating lower effectiveness.
- Ethambutol and clarithromycin showed variable MIC values depending on the source of the strains.
Takeaway
The researchers tested different antibiotics to see how well they could fight a germ that might be linked to Crohn's disease, and some worked better than others.
Methodology
The study tested 12 strains (7 from humans and 5 from animals) against various antimycobacterial agents using the BACTEC MGIT 960 method.
Limitations
The study's findings may not be generalizable beyond the specific strains tested.
Participant Demographics
7 human strains and 5 animal strains were tested.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website